BioSpace News Archive

ulrich medical USA, Inc., a privately held medical device company focused on developing and commercializing musculoskeletal implant technologies in the United States, announced it will relocate its US headquarters to Plano, Texas.

Northwell Health’s Division of Rheumatology and The Feinstein Institutes for Medical Research recently published in the New England Journal of Medicine (NEJM) data showing that an experimental lupus therapy reduced disease activity in joints of patients and globally improved their condition.

The latest market analysis report published by Reports and Data, titled ‘Global Acute Pharyngitis Treatment Market – Forecast to 2030,’ thoroughly examines the Acute Pharyngitis Treatment industry to provide essential data & information for the targeted readers.

Reports and Data’s Global Chlorine Dioxide Market research report is an in-depth investigation that provides an industry-wide overview of existing and emerging growth patterns, end-user analysis, and other key data that has been tested and validated by industry experts and professionals.

The latest market analysis report published by Reports and Data, titled ‘Global Germ Cell Tumor Market – Forecast to 2030,’ thoroughly examines the Germ Cell Tumor industry to provide essential data & information for the targeted readers. The report consists of quantitative and qualitative research on the market performed by our market experts.

The latest market analysis report published by Reports and Data, titled ‘Global Localized Scleroderma Market – Forecast to 2030,’ thoroughly examines the Localized Scleroderma industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Trimellitic Anhydride Market – Forecast to 2030,’ thoroughly examines the Trimellitic Anhydride industry to provide essential data & information for the targeted readers.

The European Medicines Agency’s Committee for Medicinal Products for Human Use has adopted a positive opinion for Beyfortus® for the prevention of respiratory syncytial virus lower respiratory tract disease in newborns and infants during their first RSV season.

AlzeCure Pharma announced that the company has received new data from the clinical phase I study with repeated dosing of the drug candidate ACD856, which is being developed against Alzheimer’s disease and other indications with cognitive dysfunction.

Royal Philips, a global leader in health technology, will showcase its latest innovations and cardiology solutions designed to strengthen clinical confidence, build efficiency throughout the care pathway and improve cardiac care experiences at the Transcatheter Cardiovascular Therapeutics annual meeting.